Current Urology Reports
2013
14(3):209-13
Assessment of needle guidance devices for their potential to reduce fluoroscopy time and operator hand dose during C-arm cone-beam computed tomography-guided needle interventions
M.W. Kroes, W.M.H. Busser, J.J. Fütterer, M.J. Arntz, C.M.M. Janssen, Y.L. Hoogeveen, F. de Lange & L.J. Schultze Kool
Journal of Vascular and Interventional Radiology
2013
24(6):901-6
Value of PCA3 to predict biopsy outcome and its potential role in selecting patients for multiparametric MRI
G.H.J.M. Leyten, E.A. Wierenga, J.P.M. Sedelaar, I.M. van Oort, J.J. Futterer, J.O. Barentsz, J.A. Schalken & P.F.A. Mulders
International Journal of Molecular Sciences
2013
14(6):11347-55
Microbrachytherapy using holmium-166 acetylacetonate microspheres: a pilot study in a spontaneous cancer animal model
W. Bult, M.A.D. Vente, E. Vandermeulen, I. Gielen, P.R. Seevinck, J. Saunders, A.D. van het Schip, C.J.G. Bakker, G.C. Krijger, K. Peremans & J.F.W. Nijsen
Brachytherapy
2013
12(2):171-7
Clinical applications of multiparametric MRI within the prostate cancer diagnostic pathway
L. Dickinson, H.U. Ahmed, C. Allen, J.O. Barentsz, B. Carey, J.J. Fütterer, S.W. Heijmink, P. Hoskin, A.P. Kirkham, A.R. Padhani, C.M.R. Persad, J. van der Meulen, A. Villers, M. Emberton & PREDICT Consensus Panel
Urologic Oncology
2013
31(3):281-4
Differentiation of prostatitis and prostate cancer by using diffusion-weighted MR imaging and MR-guided biopsy at 3 T
K.N.A. Nagel, M.G. Schouten, T. Hambrock, G.J.S. Litjens, C.M.A. Hoeks, B. ten Haken, J.O. Barentsz & J.J. Fütterer
Radiology
2013
267(1):164-72
MRI-based biodistribution assessment of holmium-166 poly(L-lactic acid) microspheres after radioembolisation
G.H. van de Maat, P.R. Seevinck, M. Elschot, M.L.J. Smits, H. de Leeuw, A.D. van het Schip, M.A.D. Vente, B.A. Zonnenberg, H.W.A.M. de Jong, M.G.E.H. Lam, M.A. Viergever, M.A.A.J. van den Bosch, J.F.W. Nijsen & C.J.G. Bakker
European Radiology
2013
23(3):827-35
Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer
D.M. Somford, C.M. Hoeks, C.A. Hulsbergen-van de Kaa, T. Hambrock, J.J. Fütterer, J.A. Witjes, C.H. Bangma, H. Vergunst, G.A. Smits, J.R. Oddens, I.M. van Oort, J.O. Barentsz & MR-PRIAS Collaboration Group
Investigative Radiology
2013
48(3):152-7
Quantitative Evaluation of Treatment Related Changes on Multi-Parametric MRI after Laser Interstitial Thermal Therapy of Prostate Cancer
S. Viswanath, R. Toth, M. Rusu, D. Sperling, H. Lepor, J.J. Fütterer & A Madabhushi
Proceedings of SPIE
2013
8671:86711F
Correlating signs and symptoms with pubovisceral muscle avulsions on magnetic resonance imaging
K. Lammers, J.J. Fütterer, J. Inthout, M. Prokop, M.E. Vierhout & K.B. Kluivers
American Journal of Obstetrics and Gynecology
2013
208(2):148.e1-7
Alginate-lanthanide microspheres for MRI-guided embolotherapy
C. Oerlemans, P.R. Seevinck, G.H. van de Maat, H. Boulkhrif, C.J.G. Bakker, W.E. Hennink & J.F.W. Nijsen
Acta Biomaterialia
2013
9(1):4681-7
Intratumoral administration of holmium-166 acetylacetonate microspheres: antitumor efficacy and feasibility of multimodality imaging in renal cancer
W. Bult, S.G.C. Kroeze, M. Elschot, P.R. Seevinck, F.J. Beekman, H.W.A.M. de Jong, D.R.A. Uges, J.G.W. Kosterink, P.R. Luijten, W.E. Hennink, A.D. van het Schip, J.L.H.R. Bosch, J.F.W. Nijsen & J.J.M. Jans
PLoS One
2013
8(1):e52178
Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway?
L. Dickinson, H.U. Ahmed, C. Allen, J.O. Barentsz, B. Carey, J.J. Futterer, S.W. Heijmink, P. Hoskin, A.P. Kirkham, A.R. Padhani, R. Persad, P. Puech, S. Punwani, A. Sohaib, B. Tombal, A. Villers & M. Emberton
Journal of Magnetic Resonance Imaging
2013
37(1):48-58
Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging
C.M.A. Hoeks, T. Hambrock, D. Yakar, C.A. Hulsbergen-van de Kaa, T. Feuth, J.A. Witjes, J.J. Fütterer & J.O. Barentsz
Radiology
2013
266(1):207-17
The evolution of radioembolisation
M.L.J. Smits, M.A.A.J. van den Bosch, J.F.W. Nijsen & B.A. Zonnenberg
Lancet Oncology
2012
13(12):e519
Journal of Magnetic Resonance Imaging
2016
44(6):1572-1579
Diagnosing pubovisceral avulsions: a systematic review of the clinical relevance of a prevalent anatomical defect
K. Lammers, J.J. Fütterer, M. Prokop, M.E. Vierhout & K.B. Kluivers
International Urogynecology Journal
2012
23(12):1653-64
Results after simultaneous surgery and RFA liver ablation for patients with colorectal carcinoma and synchronous liver metastases
M.J. van Amerongen, E.P. van der Stok, J.J. Fütterer, S.F.M. Jenniskens, A. Moelker, C. Verhoef, D.J. Grünhagen & J.H.W. de Wilt
European Journal of Surgical Oncology
2019
45(12):2334-2339
Transendocardial cell injection is not superior to intracoronary infusion in a porcine model of ischaemic cardiomyopathy: a study on delivery efficiency
T.I.G. van der Spoel, K.R. Vrijsen, S. Koudstaal, J.P.G. Sluijter, J.F.W. Nijsen, H.W. de Jong, I.E. Hoefer, M.M. Cramer, P.A. Doevendans, E. van Belle & S.A.J. Chamuleau
Journal of Cellular and Molecular Medicine
2012
16(11):2768-76
Radiologic Clinics Of North America
2012
50(6):1075-83
Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers
C.M.A. Hoeks, M.G. Schouten, J.G.R. Bomers, S.P. Hoogendoorn, C.A. Hulsbergen-van de Kaa, T. Hambrock, H. Vergunst, J.P.M. Sedelaar, J.J. Fütterer & J.O. Barentsz
European Urology
2012
62(5):902-9
Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study
M.L.J. Smits, J.F.W. Nijsen, M.A.A.J. van den Bosch, M.G.E.H. Lam, M.A.D. Vente, W.P.T.M. Mali, A.D. van het Schip & B.A. Zonnenberg
Lancet Oncology
2012
13(10):1025-34
MRI-guided interventions for the treatment of prostate cancer
J.G.R. Bomers, J.P.M. Sedelaar, J.O. Barentsz & J.J. Fütterer
America Journal of Roentgenology
2012
199(4):714-20
High-risk prostate cancer: value of multi-modality 3T MRI-guided biopsies after previous negative biopsies
J.J. Fütterer, S. Verma, T. Hambrock, D. Yakar & J.O. Barentsz
Abdominal Imaging
2012
37(5):892-6
Intra-thoracic mass on CT in a breast cancer patient
L. Heijmen, J.J. Fütterer & H.W.M. van Laarhoven
The Netherlands Journal of Medicine
2012
70(6):283, 286
Magnetic resonance imaging-based radiation-absorbed dose estimation of 166Ho microspheres in liver radioembolization
P.R. Seevinck, G.H. van de Maat, T.C. de Wit, M.A.D. Vente, J.F.W. Nijsen & C.J.G. Bakker
International Journal of Radiation Oncology/Biology/Physics
2012
83(3):e437-44
MRI-guided and robotic-assisted prostate biopsy
J.J. Fütterer & J.O. Barentsz
Current opinion in Urology
2012
22(4):316-9
ESUR prostate MR guidelines 2012
J.O. Barentsz, J. Richenberg, R. Clements, P. Choyke, S. Verma, G. Villeirs, O. Rouviere, V. Logager, J.J. Fütterer & European Society of Urogenital Radiology
European Radiology
2012
22(4):746-57
Radioactive holmium acetylacetonate microspheres for interstitial microbrachytherapy: an in vitro and in vivo stability study
W. Bult, H. de Leeuw, O.M. Steinebach, M.J. van der Bom, H.Th. Wolterbeek, R.M.A. Heeren, C.J.G. Bakker, A.D. van het Schip, W.E. Hennink & J.F.W. Nijsen
Pharmaceutical Research
2012
29(3):827-36
Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series
D.M. Somford, T. Hambrock, C.A. Hulsbergen-van de Kaa, J.J. Fütterer, I.M. van Oort, J.P. van Basten, H.F. Karthaus, J.A. Witjes & J.O. Barentsz
Investigative Radiology
2012
47(3):153-8
Evaluation of a robotic technique for transrectal MRI-guided prostate biopsies
M.G. Schouten, J.G.R. Bomers, D. Yakar, H.J. Huisman, E. Rothgang, D. Bosboom, T.W.J. Scheenen, S. Misra & J.J. Fütterer
European Radiology
2012
22(2):476-83
Predictive value of MRI in the localization, staging, volume estimation, assessment of aggressiveness, and guidance of radiotherapy and biopsies in prostate cancer
D. Yakar, O.A. Debats, J.G.R. Bomers, M.G. Schouten, P.C. Vos, E. van Lin, J.J. Fütterer & J.O. Barentsz
Journal of Magnetic Resonance Imaging
2012
35(1):20-31
Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T
M.W. Lagemaat, C.M. Zechmann, J.J. Fütterer, E. Weiland, J. Lu, G.M. Villeirs, B.A. Holshouser, P. van Hecke, M. Lemort, H.P. Schlemmer, J.O. Barentsz, S.O. Roell, A. Heerschap & T.W.J. Scheenen
Journal of Magnetic Resonance Imaging
2012
35(1):166-73
Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort
T. Hambrock, C. Hoeks, C. Hulsbergen-van de Kaa, T. Scheenen, J.J. Fütterer, S. Bouwense, I.M. van Oort, F. Schröder, H.J. Huisman & J.O. Barentsz
European Urology
2012
61(1):177-84
Quantitative evaluation of scintillation camera imaging characteristics of isotopes used in liver radioembolization
M. Elschot, J.F.W. Nijsen, A.J. Dam & H.W.A.M. de Jong
PLoS One
2010
6(11):e26174